Increasing intensity of therapies assigned at diagnosis does not improve survival of adults with acute myeloid leukemia by Krug, U, Berdel, W E, Gale, R P, Haferlach, C, Schnittger, S, Müller-Tidow, C, Braess, J, Spiekermann, K, Staib, P, Beelen, D, Serve, H, Schliemann, C, Stelljes, M, Balleisen, L, Maschmeyer, G, Grüneisen, A, Eimermacher, H, Giagounidis, A, Rasche, H, Hehlmann, R, Lengfelder, E, Thiel, E, Reichle, A, Aul, C, Ludwig, W-D, Kern, W, Haferlach, T, Köpcke, W, Görlich, D, Sauerland, M C, Heinecke, A, Wörmann, B J, Hiddemann, W, Büchner, T

Get full text

Age, not therapy intensity, determines outcomes of adults with acute myeloid leukemia by Büchner, T, Krug, U O, Peter Gale, R, Heinecke, A, Sauerland, M C, Haferlach, C, Schnittger, S, Haferlach, T, Müller-Tidow, C, Stelljes, M, Mesters, R M, Serve, H L, Braess, J, Spiekermann, K, Staib, P, Grüneisen, A, Reichle, A, Balleisen, L, Eimermacher, H, Giagounidis, A, Rasche, H, Lengfelder, E, Görlich, D, Faldum, A, Köpcke, W, Hehlmann, R, Wörmann, B J, Berdel, W E, Hiddemann, W

Get full text

CHO(E)P-14 followed by alemtuzumab consolidation in untreated peripheral T cell lymphomas: final analysis of a prospective phase II trial by Binder, C., Ziepert, M., Pfreundschuh, M., Dührsen, U., Eimermacher, H., Aldaoud, A., Rosenwald, A., Loeffler, M., Schmitz, N., Truemper, L.

Get full text

Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with... by Hiddemann, Wolfgang, Kneba, Michael, Dreyling, Martin, Schmitz, Norbert, Lengfelder, Eva, Schmits, Rudolf, Reiser, Marcel, Metzner, Bernd, Harder, Harriet, Hegewisch-Becker, Susanna, Fischer, Thomas, Kropff, Martin, Reis, Hans-Edgar, Freund, Mathias, Wörmann, Bernhard, Fuchs, Roland, Planker, Manfred, Schimke, Jörg, Eimermacher, Hartmut, Trümper, Lorenz, Aldaoud, Ali, Parwaresch, Reza, Unterhalt, Michael

Get full text

CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThe... by Pfreundschuh, Michael, Prof, Kuhnt, Evelyn, MSc, Trümper, Lorenz, Prof, Österborg, Anders, Prof, Trneny, Marek, Prof, Shepherd, Lois, MD, Gill, Devinder S, MD, Walewski, Jan, MD, Pettengell, Ruth, Prof, Jaeger, Ulrich, Prof, Zinzani, Pier-Luigi, MD, Shpilberg, Ofer, Prof, Kvaloy, Stein, Prof, de Nully Brown, Peter, MD, Stahel, Rolf, MD, Milpied, Noel, Prof, López-Guillermo, Armando, MD, Poeschel, Viola, MD, Grass, Sandra, MD, Loeffler, Markus, Prof, Murawski, Niels, MD

Get full text

Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL by Pfreundschuh, Michael, Trümper, Lorenz, Kloess, Marita, Schmits, Rudolf, Feller, Alfred C., Rübe, Christian, Rudolph, Christian, Reiser, Marcel, Hossfeld, Dieter K., Eimermacher, Hartmut, Hasenclever, Dirk, Schmitz, Norbert, Loeffler, Markus

Get full text

Complete remission and early death after intensive chemotherapy in patients aged 60 years or older with acute myeloid leukaemia: a web-based application for prediction of outcomes by Krug, Utz, Dr, Röllig, Christoph, MD, Koschmieder, Anja, Heinecke, Achim, PhD, Sauerland, Maria Cristina, MSc, Schaich, Markus, Prof, Thiede, Christian, Prof, Kramer, Michael, Braess, Jan, Prof, Spiekermann, Karsten, MD, Haferlach, Torsten, Prof, Haferlach, Claudia, MD, Koschmieder, Steffen, MD, Rohde, Christian, PhD, Serve, Hubert, Prof, Wörmann, Bernhard, Prof, Hiddemann, Wolfgang, Prof, Ehninger, Gerhard, Prof, Berdel, Wolfgang E, Prof, Büchner, Thomas, Prof, Müller-Tidow, Carsten, Prof

Get full text

Randomized comparison of busulfan and hydroxyurea in chronic myelogenous leukemia : prolongation of survival by hydroxyurea by HEHLMANN, R, HEIMPEL, H, WUSSOW, P. V, BARTRAM, C, GRIESSHAMMER, M, BERGMANN, L, ESSERS, U, FALGE, C, HOCHHAUS, A, QUEISSER, U, SICK, C, MEYER, P, HASFORD, J, SCHMITZ, N, VERPOORT, K, EIMERMACHER, H, WALTHER, F, WESTERHAUSEN, M, KLEEBERG, U. R, HEILEIN, A, KÄBISCH, A, BARZ, C, ZIMMERMANN, R, KOLB, H. J, MEURET, G, TICHELLI, A, BERDEL, W. E, KANZ, L, ANGER, B, TIGGES, F. J, SCHMID, L, BROCKHAUS, W, ZANKOVICH, R, SCHLÄFER, U, PRALLE, H, WEISSENFELS, I, MAINZER, K, TOBLER, A, PERKER, M, HOHNLOSER, J, MESSENER, D, THIELE, J, BUHR, T, ANSARI, H, HOSSFELD, D. K, QUEISSER, W, LÖFFLER, H, HEINZE, B, GEORGII, A

Get full text

9210 Bendamustine vs. fludarabine as second-line treatment in chronic lymphocytic leukemia by Medgenberg, D, Balleisen, L, Heit, W, Knauf, W, Weib, J, Freier, W, Eimermacher, H, Ibach, S, Niederle, N

Get full text

Monoallelic CEBPA mutations in normal karyotype acute myeloid leukemia: independent favorable prognostic factor within NPM1 mutated patients by Dufour, Annika, Schneider, Friederike, Hoster, Eva, Benthaus, Tobias, Ksienzyk, Bianka, Schneider, Stephanie, Kakadia, Purvi M., Sauerland, Maria-Cristina, Berdel, Wolfgang E., Büchner, Thomas, Wörmann, Bernhard, Braess, Jan, Subklewe, Marion, Hiddemann, Wolfgang, Bohlander, Stefan K., Spiekermann, Karsten

Get full text

Subgroup specific therapy effects in AML: AMLCG data by Büchner, Th, Hiddemann, W, Berdel, W E, Wörmann, B, Schoch, C, Fonatsch, C, Löffler, H, Haferlach, T, Ludwig, W D, Maschmeyer, G, Staib, P, Balleisen, L, Grüneisen, A, Aul, C, Lengfelder, E, Hehlmann, R, Kern, W, Serve, H L, Mesters, R M, Eimermacher, H, Frickhofen, N, Kienast, J, Giagounidis, A, Sauerland, M C, Heinecke, A

Get full text

Granulocyte colony-stimulating factor shortens duration of critical neutropenia and prolongs disease-free survival after sequential high-dose cytosine arabinoside and mitoxantrone... by KERN, W, AUL, C, HIDDEMANN, W, MASCHMEYER, G, KUSE, R, KERKHOFF, A, GROTE-METKE, A, EIMERMACHER, H, KUBICA, U, WÖRMANN, B, BÜCHNER, T

Get full text

Treatment of older patients with AML by Büchner, Thomas, Berdel, Wolfgang E., Wörmann, Bernhard, Schoch, Claudia, Haferlach, Torsten, Schnittger, Susanne, Kern, Wolfgang, Aul, Carlo, Lengfelder, Eva, Schumacher, Andrea, Reichle, Albrecht, Staib, Peter, Balleisen, Leopold, Eimermacher, Hartmut, Grüneisen, Andreas, Rasche, Herbert, Sauerland, Maria Cristina, Heinecke, Achim, Mesters, Rolf M., Serve, Hubert L., Kienast, Joachim, Hiddemann, Wolfgang

Get full text

Failure of fluconazole prophylaxis to reduce mortality or the requirement of systemic amphotericin B therapy during treatment for refractory acute myeloid leukemia : Results of a p... by KERN, W, BEHRE, G, RUDOLF, T, KERKHOFF, A, GROTE-METKE, A, EIMERMACHER, H, KUBICA, U, WÖRMANN, B, BÜCHNER, T, HIDDEMANN, W

Get full text

Clinical aspects of acute myeloid leukemias of the FAB types M3 and M4Eo by HAFERLACH, T, GASSMANN, W, SCHLEGELBERGER, B, NOWROUSIAN, M. R, LENGFELDER, E, EIMERMACHER, H, WEH, H. J, BRAUMANN, D, MASCHMEYER, G, KOCH, P, HEINECKE, A, SAUERLAND, M. C, LÖFFLER, H, BÜCHNER, T, JÜRGENSEN, C, NOAK, J, LUDWIG, W.-D, THIEL, E, HAASE, D, FONATSCH, C, BECHER, R

Get full text

Chromosome aberrations are restricted to the CD56+, CD3− tumour cell population in natural killer cell lymphomas: a combined immunophenotyping and FISH study by Zhang, Yanming, Wong, Kit Fai, Siebert, Reiner, Matthiesen, Peter, Harder, Svetlana, Eimermacher, Hartmut, Feller, Alfred C., Schlegelberger, Brigitte

Get full text

Remission induction therapy : the more intensive the better? by BÜCHNER, Thomas, HIDDEMANN, Wolfgang, ANDREESEN, Reinhard, BALLEISEN, Leopold, HAASE, Detlef, EIMERMACHER, Hartmut, AUL, Carlo, RASCHE, Herbert, UHLIG, Jens, GRÜNEISEN, Andreas, REIS, Hans Edgar, HARTLAPP, Joachim, BERDEL, Wolfgang, HIRSCHMANN, Wolf-Dietrich, WEH, Hans-Josef, PIELKEN, Hermann-Josef, GASSMANN, Winfried, SAUERLAND, Maria-Cristina, HEINECKE, Achim, WÖRMANN, Bernhard, LÖFFLER, Helmut, SCHOCH, Claudia, HAFERLACH, Torsten, LUDWIG, Wolf-Dieter, MASCHMEYER, Georg, STAIB, Peter

Get full text

Failure of fluconazole prophylaxis to reduce mortality or the requirement of systemic amphotericin B therapy during treatment for refractory acute myeloid leukemia: results of a pr... by Kern, W, Behre, G, Rudolf, T, Kerkhoff, A, Grote-Metke, A, Eimermacher, H, Kubica, U, Wörmann, B, Büchner, T, Hiddemann, W

Get full text

Granulocyte colony-stimulating factor shortens duration of critical neutropenia and prolongs disease-free survival after sequential high-dose cytosine arabinoside and mitoxantrone... by Kern, W, Aul, C, Maschmeyer, G, Kuse, R, Kerkhoff, A, Grote-Metke, A, Eimermacher, H, Kubica, U, Wörmann, B, Büchner, T, Hiddemann, W

Get full text

Randomized comparison of interferon-α with busulfant and hydroxyurea in chronic myelogenous leukemia by HEHLMANN, R, HEIMPEL, H, GEORGI, A, BARTTRAM, C. R, GRIESSHAMMER, M, BERGMANN, L, ESSERS, U, FALGE, C, QUEISSER, U, MEYER, P, SCHMITZ, N, EIMERMACHER, H, HASFORD, J, WALTHER, F, FETT, W, KLEEBERG, U. R, KÄBISCH, A, NERL, C, ZIMMERMANN, R, MEURET, G, TICHELLI, A, KANZ, L, TIGGES, F.-J, KOLB, H. J, SCHMID, L, BROCKHAUS, W, TOBLER, A, REITER, A, PERKER, M, EMMERICH, B, VERPOORT, K, ZANKOVICH, R, WUSSOW, P. V, PRÜMMER, O, PRALLE, H, THIELE, J, BUHR, T, CARBONELL, F, ANSARI, H, HOSSFELD, D. K, QUEISSER, W, LÖFFLER, H, HOCHHAUS, A, HEINZE, B

Get full text